Actinogen Medical Ltd $ 0.02 0 (0%)
Volume:
0
Avg Vol (1m):
0
Market Cap $:
23.51 Mil
Enterprise Value $:
19.92 Mil
P/E (TTM):
0.00
P/B:
2.20
Financial Strength |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | 12.92 | ||
Debt-to-Equity | 0.04 | ||
Debt-to-EBITDA | -0.08 | ||
Piotroski F-Score | 2 | ||
Beneish M-Score | 137.9 | ||
WACC vs ROIC |
Profitability Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
ROE % | -41.4 | ||
ROA % | -38.66 | ||
ROC (Joel Greenblatt) % | -1176.91 | ||
3-Year EBITDA Growth Rate | 7.2 | ||
3-Year EPS without NRI Growth Rate | 2.6 |
ATGGF
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
PB Ratio | 2.2 | ||
EV-to-EBIT | -5.14 | ||
EV-to-EBITDA | -5.58 | ||
Current Ratio | 10.97 | ||
Quick Ratio | 10.97 |
Dividend & Buy Back |
Current | Vs Industry | Vs History | |
---|---|---|---|
3-Year Average Share Buyback Ratio | -21.6 |
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Price-to-Tangible-Book | 2.4 | ||
Earnings Yield (Greenblatt) % | -19.46 |